Pricing
Login
Home
Charts
Search
Watchlist
Products

Vilin Bio Med Ltd

VILINBIO
₹52.75+3.13%20 Nov 2026
Reports
Pharma CRAMS

Vilin Bio Med Ltd

VILINBIO
₹52.75
+3.13%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹80Cr
Close
Close Price
₹52.75
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
26.24
PS
Price To Sales
1.23
Revenue
Revenue
₹65Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2025Mar 2026Sep 2026
Revenue
RevenueCr
103333
Growth YoY
Revenue Growth YoY%
237.5
Expenses
ExpensesCr
93031
Operating Profit
Operating ProfitCr
032
OPM
OPM%
3.48.86.0
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
000
Depreciation
DepreciationCr
000
PBT
PBTCr
032
Tax
TaxCr
010
PAT
PATCr
021
Growth YoY
PAT Growth YoY%
753.3
NPM
NPM%
1.65.53.9
EPS
EPS₹
0.11.20.8
QuarterSep 2025Mar 2026Sep 2026
Revenue
RevenueCr
103333
Growth YoY
Revenue Growth YoY%
237.5
Expenses
ExpensesCr
93031
Operating Profit
Operating ProfitCr
032
OPM
OPM%
3.48.86.0
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
000
Depreciation
DepreciationCr
000
PBT
PBTCr
032
Tax
TaxCr
010
PAT
PATCr
021
Growth YoY
PAT Growth YoY%
753.3
NPM
NPM%
1.65.53.9
EPS
EPS₹
0.11.20.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
154265
Growth
Revenue Growth%
185.3
Expenses
ExpensesCr
143960
Operating Profit
Operating ProfitCr
135
OPM
OPM%
5.37.57.4
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
100
Depreciation
DepreciationCr
000
PBT
PBTCr
035
Tax
TaxCr
011
PAT
PATCr
023
Growth
PAT Growth%
777.3
NPM
NPM%
1.54.64.7
EPS
EPS₹
0.21.42.0
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
154265
Growth
Revenue Growth%
185.3
Expenses
ExpensesCr
143960
Operating Profit
Operating ProfitCr
135
OPM
OPM%
5.37.57.4
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
100
Depreciation
DepreciationCr
000
PBT
PBTCr
035
Tax
TaxCr
011
PAT
PATCr
023
Growth
PAT Growth%
777.3
NPM
NPM%
1.54.64.7
EPS
EPS₹
0.21.42.0
Sales CAGR
1 Year185%
3 Years-
5 Years-
TTM-
EBITDA CAGR
1 Year309%
3 Years-
5 Years-
TTM-
PAT CAGR
1 Year777%
3 Years-
5 Years-
TTM-
Avg. ROCE
1 Year10%
3 Years-
5 Years-
TTM16%
CFO / EBITDA
1 Year22%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2026Sep 2026
Equity Capital
Equity CapitalCr
1515
Reserves
ReservesCr
1314
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
3539
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr
3539
Financial YearMar 2026Sep 2026
Equity Capital
Equity CapitalCr
1515
Reserves
ReservesCr
1314
Current Liabilities
Current LiabilitiesCr
Non Current Liabilities
Non Current LiabilitiesCr
Total Liabilities
Total LiabilitiesCr
3539
Current Assets
Current AssetsCr
Non Current Assets
Non Current AssetsCr
Total Assets
Total AssetsCr
3539

Cash Flow

Consolidated
Standalone
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
1
Investing Cash Flow
Investing Cash FlowCr
0
Financing Cash Flow
Financing Cash FlowCr
1
Net Cash Flow
Net Cash FlowCr
1
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
36.3
CFO To EBITDA
CFO To EBITDA%
21.9
Financial YearMar 2026
Operating Cash Flow
Operating Cash FlowCr
1
Investing Cash Flow
Investing Cash FlowCr
0
Financing Cash Flow
Financing Cash FlowCr
1
Net Cash Flow
Net Cash FlowCr
1
Free Cash Flow
Free Cash FlowCr
CFO To PAT
CFO To PAT%
36.3
CFO To EBITDA
CFO To EBITDA%
21.9

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5680
Price To Earnings
Price To Earnings
29.026.2
Price To Sales
Price To Sales
1.31.2
Price To Book
Price To Book
2.02.8
EV To EBITDA
EV To EBITDA
17.116.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
5.37.57.4
NPM
NPM%
1.54.64.7
ROCE
ROCE%
10.216.2
ROE
ROE%
6.810.3
ROA
ROA%
5.57.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5680
Price To Earnings
Price To Earnings
29.026.2
Price To Sales
Price To Sales
1.31.2
Price To Book
Price To Book
2.02.8
EV To EBITDA
EV To EBITDA
17.116.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
5.37.57.4
NPM
NPM%
1.54.64.7
ROCE
ROCE%
10.216.2
ROE
ROE%
6.810.3
ROA
ROA%
5.57.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr230149128123908072
Close PriceClose₹207.00135.00158.0057.0868.5152.7539.45
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.2443.83
Price To SalesPS2.281.091.834.580.931.230.91
RevenueRevenueCr1011377027976578
Revenue Growth TTMRev Gr TTM%22.3%54.7%-1.4%114.4%17.9%
PAT Growth TTMPAT Gr TTM%44.5%-3.4%51.4%410.3%52.3%
Market CapitalizationMkt CapCr230149128123908072
Close PriceClose₹207.00135.00158.0057.0868.5152.7539.45
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.2443.83
Price To SalesPS2.281.091.834.580.931.230.91
RevenueRevenueCr1011377027976578
Revenue Growth TTMRev Gr TTM%22.3%54.7%-1.4%114.4%17.9%
PAT Growth TTMPAT Gr TTM%44.5%-3.4%51.4%410.3%52.3%
Annual Reports
FY2025
FY2024
FY2023
Quarterly Reports
FY2026
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Load More
Interviews